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Abstract Rhomboid domain containing 2 (RHBDD2) was
previously observed overexpressed and amplified in breast can-
cer samples. In order to identify biological pathways modulated
by RHBDD2, gene expression profiles of RHBDD2 silenced
breast cancer cells were analyzed using whole genome human
microarray. Among the statistically significant overrepresented
biological processes, we found protein metabolism—with the
associated ontological terms folding , ubiquitination , and
proteosomal degradation—cell death , cell cycle , and oxidative
phosphorylation . In addition, we performed an in silico analysis
searching for RHBDD2 co-expressed genes in several human
tissues. Interestingly, the functional analysis of these genes
showed similar results to those obtained with the microarray
data, with negative regulation of protein metabolism and oxi-
dative phosphorylation as the most enriched gene ontology
terms. These data led us to hypothesize that RHBDD2 might
be involved in endoplasmic reticulum (ER) stress response.
Thus, we specifically analyzed the unfolding protein response
(UPR) of the ER stress process. We used a lentivirus-based
approach for stable silencing of RHBDD2 mRNA in the T47D
breast cancer cell line, and we examined the transcriptional
consequences on UPR genes as well as the phenotypic effects
on migration and proliferation processes. By employing
dithiothreitol as an UPR inducer, we observed that cells with
silenced RHBDD2 showed increased expression of ATF6,
IRE1, PERK, CRT, BiP, ATF4, and CHOP (p <0.01). We also
observed that RHBDD2 silencing inhibited colony formation
and decreased cell migration. Based on these studies, we hy-
pothesize that RHBDD2 overexpression in breast cancer could
represent an adaptive phenotype to the stressful tumor microen-
vironment by modulating the ER stress response.
Keywords RHBDD2 . Breast cancer . ER stress . UPR
Introduction
The Rhomboid gene family constitutes a heterogeneous group of
proteases that are conserved throughout evolution (Freeman
2008). Rhomboid 1, from Drosophila melanogaster, was the
first member described in this family (Sturtevant et al. 1993).
Since then, many genes have been classified as rhomboids based
on sequence similarities despite lacking a catalytic domain.
These members therefore have been denominated rhomboid
pseudoproteases. So far, 14 human rhomboid family member
proteins have been identified: five rhomboid proteases
(RHBDL1/2/3/4 and PARL) and nine pseudoproteases
(iRhom1/2, Derlin1/2/3, RHBDD2/3, UBAC2, and
TMEM115) (Bergbold and Lemberg 2013).
Rhomboids have been implicated in numerous processes,
ranging from cell signaling and apoptosis to parasitic shed-
ding and endoplasmic reticulum-associated degradation
(ERAD), a cellular pathway associated to the unfolded protein
response (UPR) (McQuibban et al. 2003; Urban and Freeman
2003; Liu and Kaufman 2003; Cipolat et al. 2006; Zou et al.
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2009; Adrain et al. 2011; Fleig et al. 2012). In addition,
various rhomboid protein family members have been associ-
ated with diseases such as neurodegenerative disorders and
cancer (Whitworth et al. 2008; Zou et al. 2009; Abba et al.
2009; Blaydon et al. 2012; Lacunza et al. 2012; Etheridge
et al. 2013). The specific molecular function of several of the
proteolytically inactive rhomboids in particular remains
unknown.
In previous studies, we identified rhomboid domain con-
taining 2 (RHBDD2), a pseudoprotease family member, to be
markedly overexpressed in primary invasive breast carcinomas
from patients that developed recurrent disease (Abba et al.
2007; Abba et al. 2009). More recently, we also observed
significant RHBDD2 mRNA and protein overexpression in
the advanced stages of colorectal cancer (Lacunza et al.
2012), suggesting that RHBDD2 up-modulation might be as-
sociated with breast and colon cancer malignant progression.
We also determined that RHBDD2 protein expression is
upregulated in colon cancer cells treated with the chemothera-
peutic agent 5-fluourouracil (5FU) (Lacunza et al. 2012), which
has recently been shown to be an inducer of ER stress in
hepatocellular carcinoma cells (Yadunandam et al. 2012).
With the aim of identifying the biological processes mod-
ulated by RHBDD2 and to elucidate its role in breast cancer
progression, we report here the transcriptomic profiling of two
breast cancer cell lines transiently silenced for RHBDD2
expression. Results obtained and previous evidence led us to
hypothesize that RHBDD2 might be involved in the UPR
pathway; therefore, we evaluated the transcriptional effect of
RHBDD2 stably silenced T47D breast cancer cells on the
UPR pathway genes, as well as the phenotypic consequences
on proliferation and cell migration processes.
Material and methods
Cell culture and RHBDD2 gene expression analysis
Estrogen-dependent breast cancer cell lines MCF7 and T47D
were cultured in RPMI medium (Gibco, Gaithersburg, MD)
and Dulbecco’s modified Eagle’s medium (DMEM)
(Gibco, Gaithersburg, MD), respectively, supplemented with
10 % fetal bovine serum (FBS) (Bioser, Argentina), 10 U/mL
penicillin, and 10 μg/mL streptomycin.
RT-qPCR analysis of RHBDD2 mRNAwas evaluated for
different breast cancer cell lines. Expression of each sample
was normalized with mRNA from 18S rRNA as housekeep-
ing gene. Total RNA was isolated using TRIzol (Invitrogen,
USA) and cDNAs were synthesized using High Capacity
Reverse Transcription Kit (Applied Biosystems, USA). The
following primers were designed and used: forward 5′-
GGTGTTTGGCATGGTTGTG-3′ and reverse 5′-CGA
TGGAATAGCAGTAGGTGAG-3′. The thermal profile was
94 °C for 2 minute and then 40 cycles of 94 °C for 40 s, 57 °C
for 45 s, and 72 °C for 40 s.
Gene expression profiling of RHBDD2 silencing cells
MCF7 and T47D cell lines were cultured on 12-well plates at
40 % of confluence in Opti-MEM I Reduced Serum Medium
and were transiently transfected with 40 pmol/μL of siRNA
mixed with Lipofectamine according to the manufacturer’s pro-
tocol (Invitrogen, USA). We used a siRNA of 19-mer against
RHBDD2 mRNA (RHBDD2-siRNA, 5′-CUGUGUUGGGUA
CUUUGAUdTdT-3′) as was previously described (Abba et al.
2009). In addition, the AccuTargetTM biotin-labeled negative
control siRNA (NegCt-siRNA, 5′-CCUACGCCACCAA
UUUCGUdTdT-3′) (Bioneer Inc., South Korea) that exhibits
no homology to any human genome sequence was used as a
non-silencing reference. Cells were incubated during 72 h.
In order to analyze the differential gene expression profiling
of RHBDD2 silencing and control cells, total RNAwas isolated
from duplicate experiments using TRIzol reagent and purified
using the TRIreagent and NucleoSpin RNA Clean-up Kit
(Macherey-Nagel). RNA concentration and integrity were
measured on an Agilent Bioanalyzer RNA 6000 Nanochip
(Agilent Technologies). Briefly, aminoallyl-amplified RNA
(aRNA) was synthesized from 1 μg of total RNA with the
Amino Allyl MessageAmp™ II aRNA Amplification Kit
(Ambion) and subsequently labeled with Cy5 Mono-
ReactiveDyePack (GE Healthcare Bioscience). One micro-
gram of labeled aRNA was probed using the whole genome
Toray 3D-Gene™ Human Oligo Chip 25k V2.1 (GPL13915).
Target labeling and hybridization to Chips were carried out in
the Genomics Core Facility at Toray Inc. Raw datasets have
been submitted to NCBI GEO database with accession number
GSE43015.
Bioinformatics and statistical analysis
To compare the control siRNAvs. RHBDD2-siRNA treatments
in each breast cancer cell line models, we employed the Rank
Products’ test (Breitling et al. 2004). Statistical analysis,
heatmap visualization, and comparison of overlapping differen-
tially expressed genes betweenMCF7 and T47D cell lines were
done with the MultiExperiment Viewer software (MeV 4.8)
(Saeed et al. 2003). The number and identity of genes common-
ly affected in bothmodels were determined.We used the normal
approximation to the binomial distribution as previously de-
scribed (Smid et al. 2003) to calculate the number of matching
genes derived from each pairwise comparison at the p<0.05
statistical significance level.
For automated functional annotation and gene enrichment
analysis, we used the Database for Annotation, Visualization,
and Integrated Discovery (DAVID, http://david.niaid.nih.gov/
david) (Huang et al. 2008). The DAVID resource calculates
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overrepresentation of specific biological themes/pathways
with respect to the total number of genes assayed and anno-
tated. REViGO resource (http://revigo.irb.hr) was employed
to summarize and visualize the enriched gene ontology (GO)
terms in an interactive graph based on the p values obtained
by DAVID. This allows one to identify biological themes/
pathways within a specific list of differentially expressed
genes.
To further analyze possible pathways associated with
RHBDD2, we employed the “guilt by association” principle,
which states that gene co-expression might indicate shared
regulatorymechanisms and roles in related biological processes.
Briefly, RHBDD2 co-expressed genes in different tissue local-
izations (adrenal gland, brain, breast, colon, head and neck,
lung, ovary, small intestine, and stomach) were obtained by
using the web-based bioinformatics tool Multiexperiment
Matrix (http://biit.cs.ut.ee/mem/; Adler et al. 2009). For each
tissue, we selected the 200 best positive correlated genes
(p<0.0001), which were compiled into one Excel pivot table
for comparison of overlapping genes between the tissues,
selecting those genes that were present in at least four
localizations. Finally, we built a matrix with the selected genes
(rows) across the nine tissues (columns) and performed a hier-
archical clustering (HCL) by using the MeV 4.8. The DAVID
and REViGO tools were employed for the functional enrich-
ment analysis.
Silencing of RHBDD2 gene on T47D cells
The pLKO.1–TRC Cloning Vector (Addgene) was employed
for silencing RHBDD2 gene on the T47D cell line. pLKO.1 is
a replication-incompetent lentiviral vector that can be used for
the production of infective lentiviral particles containing the
shRNA of interest using the HEK293T helper cell line.
Following manufacturer’s instructions, a target sequence of
21 base pair oligonucleotides was designed to obtain
RHBDD2 siRNA for cloning into plKO.1: forward
ccggaaGTCTACGAGAATCCCATCTctcgagAGATGGGAT-
TCTCGTAGACtttttttg and reverse aattcaaaaaaaGTCTA
CGAGAATCCCATCTctcgaGAGATGGGATTCTCGTAG-
ACTT. Capital letters indicate sense and antisense target se-
quences. These sequences are flanked by sequences that are
compatible with the sticky ends of EcoRI and AgeI restriction
enzymes. After digestion, forward and reverse oligos were
annealed and ligated into the pLKO.1 vector, producing a final
plasmid that expresses the RHBDD2 shRNA. Plasmid was
transformed into 25 μL competent DH5 alpha cells and plated
on lysogeny broth (LB) agar plates containing 100 μg/mL
ampicillin. Colonies were grown in LB/100 μg/mL ampicillin
and DNA was purified by using a Miniprep Kit (Qiagen,
USA). Positive clones were verified by conducting a sequenc-
ing reaction. To produce lentiviral particles, 1 μg of plKO1-
shRNA RHBDD2 and plKO1-shRNA scramble (provided
with the kit) were mixed in separate tubes with 750 ng of
psPAX2 packaging plasmid and 250 ng of pMD2.G envelope
plasmid. Cocktail was transfected into HEK293T cells by
using FUGENE6 transfection reagent (Roche, USA).
Twenty-four hours after transfection, media containing
lentiviral particles were harvested, and lentiviral concentration
was estimated with the lentiviral titer kit, Lenti-X GoStix
(Clontech, USA) Lentiviral infectionwas performed by adding
1 mL of lentiviral particle solution on 70 % confluent T47D
cells grown in 6 cm plates with fresh media containing 8
μg/mL polybrene. Infected cells were selected 24 h after
infection with 1 μg/mL of puromycin. Three days post-
infection, cells were harvested to the extraction of RNA and
proteins. Efficiency of the knockdown of the gene was assayed
by real-time PCR and Western blot.
Real-time quantitative PCR analysis of genes associated
with the UPR signaling pathway
To activate the UPR pathway, T47D scramble and T47D
silenced cells (shRNA1) were incubated in 10-cm plates, by
triplicate, with dithiothreitol (DTT, 2 mM) during a time series
of 4, 6, 7, and 8 h. Total RNAwas isolated from controls and
treated cells using TRI Reagent (MRC, USA). Approximately,
5 μg of the total RNAwas reverse transcribed using RevertAid
H Minus First Strand cDNA Synthesis Kit (Fermentas,
Canada). About 5 μL of cDNAwas amplified for seven UPR
pathway genes (CRT, BiP, PRKR-like endoplasmic reticulum
kinase (PERK), inositol-requiring enzyme 1 (IRE1), activating
transcription factor 6 (ATF6), activating transcription factor 4
(ATF4), and CHOP) and the data normalized to RPL19 endog-
enous control gene. Primer sequences were obtained from
Balakhrishnan et al. (2013). PCR reaction was performed in a
25-μL volume, using Taq DNA polymerase and EVA green
dye. PCR condition was set at an initial denaturation at 94 °C
for 2 min, 40 cycles at 94 °C for 40 s, 55 °C for 40 s, and 72 °C
for 40 s. For IRE1 and PERK, different annealing conditions
were employed, setting 52 °C for 40 s. Data was captured and
analyzed using the Stratagene MxPro-Mx3000P system 3.2
Software. The relative gene expression between T47D
Scramble Control cells and Scramble and shRNA1 DTT treat-
ed cells was measured by the comparative threshold cycle
(2–ΔΔCT) method, and values >2-fold were considered as dif-
ferentially regulated between groups at the p <0.05 statistical
significance level. Fold changes were always referred to the
scramble control cells.
Soft agar growth and wound healing assays
For soft agar assay, a base layer of 1.5 mL of the correspond-
ing culture media containing 0.5 % agarose and 10 % FBS
was added to 35-mm plates. After the base layer was solidi-
fied, 5,000 cells were resuspended in 1.5 mL of culture media
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containing 0.35 % agarose and 10 % FBS and added to the
plates. Plates were incubated at 37 °C in a humidified incuba-
tor for 10 to 20 days. Colonies were stained with 0.005 %
Crystal Violet and counted using an inverted microscope.
For the wound healing assay, T47D (scramble and
shRNA1) cells were grown to confluence on 10-mm plates
and wounded six times in the cell monolayer with a 200-μL
standard pipette tip. Cells were then washed twice with PBS to
remove cell debris and incubated with DMEMmedium as was
previously described. The area of cell-free wound was cap-
tured as images at 0, 24, 48, and 72 h using an inverted
microscope (Olympus, IX71) equipped with a digital camera
(Olympus) under ×100 magnification. To quantify the migra-
tion rate of the cells, the width of the wound was measured at
ten points for each time and replicate, and the mean and
standard deviation were calculated.
Results
Gene expression profiling of RHBDD2 silenced cells showed
an enrichment in ontological terms associated to ER stress
In order to identify RHBDD2-modulated pathways, we ana-
lyzed the transcriptomic profiles of breast cancer cell lines
MCF7 and T47D transiently silenced for RHBDD2 expression
(Fig. 1a, b). Statistical analysis of the gene expression profiling
data identified 541 commonly differentially expressed genes
(281 up-modulated and 260 down-modulated transcripts) in
association to the RHBDD2 knockdown in both breast cancer
cell lines (Fig. 1c and Supplementary File 1). We used the
DAVID resource for automated annotation and functional clas-
sification of the differentially expressed genes. Among the top
biofunctions, we found protein metabolism, ribosomal
Fig. 1 Transcriptional effect of RHBDD2-siRNA silencing in breast
cancer cell lines. RNA obtained from the different cell lines was run in
a denaturing agarose gel to determine the quality samples, indicated by
the presence of the ribosomal RNAs 28s and 18s. (a) The effect of the
siRNAwas then validated by real-time PCR as it is shown with the bar
chart. (b) Venn diagram showing the overlap between transcripts modu-
lated in association to RHBDD2 silencing in both breast cancer cell lines.
Statistical analysis showed a significant number of overlapping genes
between cell lines (p <0.001). (c) Scatter plot graph of the 541 commonly
deregulated genes (281 up-modulated and 260 down-modulated genes)
showing the representative clusters, after redundancy reduction of the
statistical significant GO terms (p <0.01) enriched in the deregulated gene
list, in a two-dimensional space related toGO terms’ semantic similarities.
Bubble color indicates the p value of GO terms (expressed as log10 p
value) and bubble size indicates the frequency of the GO term in the
underlying GOA database (bubbles of more general terms are larger) (d)
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biogenesis, oxidative phosphorylation, regulation of cell cycle,
and apoptosis (Fig. 1d). Protein metabolism was the ontological
term most significantly enriched. This GO cluster includes
terms associated to ER stress biology such as protein folding,
proteosomal degradation, ubiquitination, and translation
(Fig. 1d). The GO molecular functions most represented cate-
gories include terms associated with unfolded protein binding,
structural constituents of ribosomes, oxidoreductase activity,
and posttranslational protein modification.
To further explore RHBDD2-associated biological pathways
from another perspective, we performed an in silico analysis
based on the hypothesis that genes that are co-expressed in
different locations could be associated with common functional
mechanisms. We searched for RHBDD2 co-expressed genes in
different tissues and selected the 200 best correlated genes
(p <0.0001) for each tissue. Finally, we extracted genes
overlapping in at least four different tissues (>40 %), reducing
the list of genes to 87 (Fig. 2a and Supplementary File 2). The
functional classification indicated enrichment in the following
biological terms: negative regulation of protein metabolism,
vesicle-mediated transport, regulation of cell death, and mito-
chondrial metabolism (Fig. 2b). These four main categories
segregated in two main nodes of the HCL dendogram, deter-
mining two sets of functional related genes (Fig. 2a).
Interestingly, the GO terms are very similar to those found
overrepresented in the breast cancer cell line study, reinforcing
the observation that RHBDD2 might be involved in the ER
stress–protein folding-related pathway.
RHBDD2 stable silencing affects the expression of genes
associated to the UPR pathway
Gene expression profiling information led us to evaluate the
effect of RHBDD2 stable silencing in the T47D cell line on the
UPR signaling pathway under stressful ER conditions. After
verifying the knockdown of RHBDD2 at mRNA and protein
levels (Fig. 3), we evaluated seven genes falling in the three
major axes of the UPR pathway, in which the sensor molecules
are PERK, IRE1, and ATF6. The ER stress was induced by
DTT treatment in a time series of four points (4, 6, 7, and 8 h).
Fig. 2 Gene ontology classification of genes co-expressed with
RHBDD2 in multiple human tissues. Hierarchical clustering of the
resulting array of RHBDD2 co-expressed genes (N=87) and different
tissue localizations (N=9). (a) Scatter plot graph of the 87 RHBDD2
co-expressed genes showing the representative functional clusters
according GO terms with a statistical significance of p <0.01 (b)
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Interestingly, all the genes responded transiently to DTT,
reaching a peak at 4 or 6 h with a consequent significant
decrease after 7 and 8 h of exposure (Fig. 4). Importantly, cells
silenced for RHBDD2 expression showed a more dramatic
upregulation of all the responsive genes upon exposure to the
ER stressor DTTwhen compared with scrambled controls. For
instance, the expression of chaperones CRT and BiP increased
4.8- and 23-fold, respectively, in RHBDD2 silenced cells at 6 h
of treatment, compared with 1.5- and 17-fold, respectively, in
scrambled control cells (p<0.001; Fig. 4a, b). Remarkably, a
slight increase in the basal expression of both genes was also
observed in control silenced cells as compared to the control
scramble cells. The UPR sensor molecule ATF6 increased 4-
fold in expression in RHBDD2 silenced cells vs. 3.1-fold in
scramble cells (p <0.01; Fig. 4a). Furthermore, the baseline
level expression of ATF6 in RHBDD2 silenced cells unexposed
to DTT was also higher than scrambled control cells (p <0.01;
Fig. 4a). A significant increase in DTTresponse of silenced cells
was also observed in the other two sensor molecules, IRE1 and
PERK (Fig. 4a, c), being the latter the sensor molecule that
showed the highest response. Moreover, the downstream target
of PERK, ATF4, behaved similarly to the previous genes, with a
peak of 4.5-fold of expression above the scramble cells after 4 h
of exposition to DTT (p <0.01; Fig. 4c). Interestingly, CHOP, a
downstream target of ATF4 and ATF6, also showed a higher
increase of expression after DTT exposition in silenced cells
(40-fold) compared with scramble cells (32-fold), with the peak
at 4 h time point (Fig. 4c). In this sense, the results illustrate two
types of kinetics of response to DTT: one with a peak at 4 h of
treatment that includes the genes PERK, ATF4, CHOP, and
CRT and the other with a peak at 6 h, represented by ATF6,
BiP, and IRE1.
RHBDD2 stable silencing reduces anchorage-independent
growth and cell migration in vitro
In order to evaluate the phenotypic effects of RHBDD2 stable
silencing, the effect on anchorage-independent growth by the
soft agar colony formation assay was evaluated. Significantly
lower number of colonies was formed by the RHBDD2 si-
lenced cells after 10 days of culture. Whereas control cells
showed an average of 60 colonies per optical field, in silenced
cells, an average of 30 colonies was observed (p <0.01).
Furthermore, in control cells, the number of colonies contin-
ued to increase even after 20 days of culture, while RHBDD2
silenced cells showed approximately the same number of
colonies as the 10-day time point (Fig. 5a).
We also analyzed directional cell migration in vitro by
means of the standard wound healing assay. Similar to the
result obtained in colony formation, the migration rate was
significantly lower in RHBDD2 silenced cells (p <0.001) when
compared with controls, which indicates that RHBDD2 abro-
gation would also inhibit cell migration (Fig. 5b).
Discussion
In previous studies, we demonstrated that RHBDD2 is
overexpressed at mRNA and protein levels in advanced stages
of breast and colorectal carcinomas, suggesting that RHBDD2
up-modulation might be associated with tumor progression
(Abba et al. 2009: Lacunza et al. 2012). In the present study,
with the aim of identifying molecular pathways associated to
RHBDD2, by the analysis of gene expression microarray data
and subsequent experimental approaches by quantitative real-
time PCR, we determined that RHBDD2 abrogation in T47D
breast cancer cells disrupts the UPR signaling pathway, af-
fecting cellular proliferation and migration in vitro.
The UPR is mainly controlled by the sensor molecules
IRE1, ATF6, and PERK. In the absence of stress, these sensor
molecules are maintained inactive via their association with
BiP (immunoglobulin heavy chain -binding protein , also
known as GRP78 ). Upstream in the ER, the quality control
chaperone CRT (calreticulin) interacts with misfolded and
unfolded proteins to achieve a native conformation; if this is
not achieved, BiP dissociates from the molecular sensors (thus
Fig. 3 RHBDD2 stable silencing
in T47D cells. Schematic
representation of the plKo system
employed for stable silencing of
RHBDD2 and its validation at
RNA and protein level. After
inserting RHBDD2 siRNA, this is
transcribed in the form of shRNA
by the strong U6 promoter. (a)
Silencing efficiency of lentiviral
particles obtained from the plkO
system was evidenced at mRNA
and protein levels (b)
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activating them) and binds to the unfolded proteins. As a
consequence, ATF4 is activated by PERK, IRE1 is activated
by homo-oligomerization followed by autophosphorylation
which enables both its kinase and endoribonuclease activities
to transduce stress response signals, and ATF6 is translocated
to the Golgi apparatus and cleaved. The activated ATF4, the
cleaved ATF6, and the products of IRE1 signaling finally
translocate to the nucleus to bind UPR elements and induce
Fig. 4 Transcriptional effect of RHBDD2 stable silencing on UPR genes
under ER stress activation with DTT. Bar charts indicate the level of
mRNA expression of each gene under time-dependent ER stress condi-
tions in both scramble and RHBDD2 silenced cells (shRNA1) compared
to their respective controls. A significant greater increase of the molecular
sensors ATF6 and IRE1 and the chaperone BiP in response to DTT is
observed in RHBDD2 silenced cells compared with scramble cells, with
the peak of response at 6 h of treatment; additionally, these genes showed
high levels of their RNAs in the untreated silenced cells compared with
the controls (a). This situation was also evident for the chaperone CRT,
but in this case, the peak of response is observed at 4 h (b), as well as
observed for PERK, ATF4, and CHOP, which also showed a greater
response in silenced cells compared with the scramble (c). Asterisk :
Statistically significant differences (p<0.01)
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transcription of several stress genes including BiP and CHOP
(CCAAT /enhancer -binding protein homologous protein )
(Yoshida et al. 2001; Liu and Kaufman 2003; Chakrabarti
et al. 2011; Balakrishnan et al. 2013).
ER stress induction over T47D cells by using DTT showed
a transient response of all the UPR genes analyzed, reaching a
peak of expression at 4 and 6 h of treatment. Interestingly, in
all cases, the kinetics of response was higher in RHBDD2
silenced cells than scramble cells. Remarkably, results also
indicated that RHBDD2 silenced cells show an endogenous
overexpression of the UPR genes BiP, CRT, ATF6, and
CHOP, which would suggest that RHBDD2 abrogation might
be a stressful effect in itself, partially disrupting the UPR
signaling pathway. Additionally, in the balance of responses
of the three sensor molecules, PERK showed the highest
difference between the silenced and scramble cells, which
would be consequent with the also high response of the
PERK downstream genes ATF4 and CHOP. Moreover, all
these genes reached the peak of response at 4 h of treatment
compared to the delayed response shown by the other genes. It
has been established that PERK and ATF6 would be activated
before IRE1 and that this ordering would be consistent with
the signals that each branch—governed by a sensor mole-
cule—transduces (Szegezdi et al. 2006). While PERK and
ATF6 pathways promote ER adaptation to misfolding, IRE1
has a dual role, transmitting survival signals and pro-apoptotic
Fig. 5 Phenotypic effects of RHBDD2 stable silencing in the T47D cells
on colony formation and cell monolayer migration. Knocking down
RHBDD2 expression in T47D cells decreased the mean number of
colonies grown in agar. (a ) Microphotographs of T47D cell line
monolayer (×100), in which the wound is observed, are shown at three
time points. A statistical significant decrease in cell migration in
RHBDD2 silenced cells was observed (b)
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signals. According to the results shown in this study, the
branch constituted by PERK, ATF4, and CHOP would be
the more affected by RHBDD2 silencing.
Interestingly, CHOP (also known as GADD153) that was
originally identified as a member of the DNA damage re-
sponse pathway has a role in the induction of cell death by
promoting protein synthesis and oxidation in the stressed ER
(Di Sano et al. 2006). Therefore, the high expression of CHOP
in RHBDD2 silenced cells would explain at least in part the
observed decrease in cell migration and colony formation,
which would be in line with the observation that RHBDD2
transient abrogation decreased MCF7 breast cancer cell via-
bility as well (Abba et al. 2009).
The fact that RHBDD2 would be involved in the ER stress
response according to the results obtained in this study is also
supported by previous findings with RHBDD2 and with other
members of the rhomboid family. In this sense, we recently
demonstrated that the chemotherapy agent 5FU treatment on
colorectal cancer cells significantly increases RHBDD2
mRNA and protein expression, compared with the untreated
cells, suggesting that RHBDD2 up-modulation might be in-
duced as an adaptive cellular response to the 5FU cytotoxic
effects (Lacunza et al. 2012). Interestingly, a recent study
showed that 5FU promotes ER stress, activating the mito-
chondrial apoptotic cell death process (Yadunandam et al.
2012). An association of different rhomboid member’s genes
and the ER quality control process has also been established. It
was determined that Derlins 1, 2, and 3, which are rhomboid
pseudoproteases phylogenetically associated to RHBDD2,
have been involved in the ERAD, a necessary process of the
UPR before the ubiquitin-proteasome system (Oda et al. 2006;
Greenblatt et al. 2011). Similarly, the RHBDL4 protein has
been recently found upregulated upon ER stress and partici-
pates actively in the classical ERAD pathway, cleaving mem-
brane proteins with atypical positively charged transmem-
brane domains (Fleig et al. 2012).Moreover, UBAC2, another
rhomboid pseudoprotease, is upregulated under ER stress
conditions suggesting a vital role in the control of ER protein
homeostasis (Olzmann et al. 2013).
Cancer cells are often exposed to ER stress conditions,
which are originated in the tumor microenvironment such as
nutrient starvation, hypoxia, redox environment, and the acti-
vation of cellular processes that demand a high rate of protein
biosynthesis (e.g., cell proliferation). These ER stress stimuli
lead to the activation of the UPR pathway that can provide
either pro-survival signals to reestablish cellular homeostasis
or cell death signals if the stress is prolonged and unresolved
(Scriven et al. 2009; Li et al. 2011).
Several studies have also established that the interplay
between protein synthesis, ubiquitin-mediated degradation,
processing, and modification regulates a broad array of basic
cellular processes such as cell proliferation and migration
(Adams 2003; Guerriero and Brodsky 2012). Previous reports
have demonstrated that the UPR and the overexpression of
UPR genes influence on cell migration by weakening cell
adhesion to substrate promoting the rearrangement of cyto-
skeleton components, such as actins and microtubules
(Rongjian et al. 2003; Kviecinski et al 2012). In this sense,
Rongjian et al. who analyzed UPR on cell migration in organ-
ogenesis in vitro inferred that UPR would be an adaptive
mechanism for stress cells to win more time for repairing their
functions in the process of migration during organogenesis.
We found that RHBDD2 abrogation directly affects cell mi-
gration and colony formation independently of substrate an-
chorage, which might be in agreement with the idea that
stressful conditions would impact on cell fate.
In this study, we demonstrated that RHBDD2 abrogation
not only deregulates UPR gene expression, but also directly
affects cell migration and proliferation as well as the
anchorage-independent growth. In conclusion, our findings
raise the possibility that RHBDD2 overexpression could be
important for tumor cells to thrive under stressful conditions
by modulating their ER stress response; however, more stud-
ies will be necessary to confirm this hypothesis.
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